Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Alzheimer's Disease

  Free Subscription


28.04.2020

1 Acta Neuropathol
1 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 Ann Neurol
1 Brain
2 Curr Alzheimer Res
1 Exp Gerontol
1 Int J Neurosci
12 J Alzheimers Dis
1 J Clin Psychiatry
1 J Clin Psychopharmacol
2 J Neurochem
2 Lancet Neurol
2 Nat Rev Neurol
3 Neurobiol Aging
1 Neurochem Res
1 Neurology
1 Neuroscience
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. DEMAREST TG, Varma VR, Estrada D, Babbar M, et al
    Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Acta Neuropathol. 2020 Apr 24. pii: 10.1007/s00401-020-02152.
    PubMed         Abstract available


    Alzheimers Dement

  2. DE FLORES R, Wisse LEM, Das SR, Xie L, et al
    Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
    Alzheimers Dement. 2020 Apr 22. doi: 10.1002/alz.12079.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  3. BROWN EE, Kumar S, Rajji TK, Pollock BG, et al
    Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2020 Apr 18. pii: S1064-7481(20)30294.
    PubMed         Abstract available


    Ann Neurol

  4. KUMMER BR, Diaz I, Wu X, Aaroe AE, et al
    Associations between cerebrovascular risk factors and parkinson disease.
    Ann Neurol. 2019 Aug 29. doi: 10.1002/ana.25564.
    PubMed         Abstract available

  5. SCHULTZ A, Kloet RW, Sohrabi HR, van der Weerd L, et al
    Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers.
    Ann Neurol. 2019 Jul 30. doi: 10.1002/ana.25560.
    PubMed         Abstract available


    Brain

  6. SPOTORNO N, Acosta-Cabronero J, Stomrud E, Lampinen B, et al
    Relationship between cortical iron and tau aggregation in Alzheimer's disease.
    Brain. 2020 Apr 24. pii: 5824902. doi: 10.1093.
    PubMed         Abstract available


    Curr Alzheimer Res

  7. PRENDECKI M, Kowalska M, Toton E, Kozubski W, et al
    Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders.
    Curr Alzheimer Res. 2020 Apr 22. pii: CAR-EPUB-106018.
    PubMed         Abstract available

  8. HU C, Hu J, Meng X, Zhang H, et al
    L1CAM Beneficially Inhibits Histone Deacetylase 2 Expression under Conditions of Alzheimer's Disease.
    Curr Alzheimer Res. 2020 Apr 22. pii: CAR-EPUB-106019.
    PubMed         Abstract available


    Exp Gerontol

  9. KIM YJ, Kim SH, Park Y, Park J, et al
    miR-16-5p is upregulated by amyloid beta deposition in Alzheimer's disease models and induces neuronal cell apoptosis through direct targeting and suppression of BCL-2.
    Exp Gerontol. 2020 Apr 19:110954. doi: 10.1016/j.exger.2020.110954.
    PubMed         Abstract available


    Int J Neurosci

  10. ARSLAN ME, Turkez H, Mardinoglu A
    In vitro neuroprotective effects of farnesene sesquiterpene on alzheimer's disease model of differentiated neuroblastoma cell line.
    Int J Neurosci. 2020 Apr 19:1-10. doi: 10.1080/00207454.2020.1754211.
    PubMed         Abstract available


    J Alzheimers Dis

  11. INNES KE, Sambamoorthi U
    The Association of Osteoarthritis and Related Pain Burden to Incident Alzheimer's Disease and Related Dementias: A Retrospective Cohort Study of U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD191311. doi: 10.3233/JAD-191311.
    PubMed         Abstract available

  12. LEE SH, Byun MS, Lee JH, Yi D, et al
    Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    J Alzheimers Dis. 2020 Apr 18. pii: JAD191216. doi: 10.3233/JAD-191216.
    PubMed         Abstract available

  13. CAI HB, Fan ZZ, Tian T, Li ZC, et al
    Diabetes-Induced H3K9 Hyperacetylation Promotes Development of Alzheimer's Disease Through CDK5.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200163. doi: 10.3233/JAD-200163.
    PubMed         Abstract available

  14. LIU B, Liu J, Shi JS
    SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200063. doi: 10.3233/JAD-200063.
    PubMed         Abstract available

  15. YOUN YC, Lee BS, Kim GJ, Ryu JS, et al
    Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD200061. doi: 10.3233/JAD-200061.
    PubMed         Abstract available

  16. HUANG SY, Zhu JX, Shen XN, Xu W, et al
    Prevalence of the Preclinical Stages of Alzheimer's Disease in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200059. doi: 10.3233/JAD-200059.
    PubMed         Abstract available

  17. WESTFALL S, Dinh DM, Pasinetti GM
    Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191328. doi: 10.3233/JAD-191328.
    PubMed         Abstract available

  18. HENDERSON ST, Morimoto BH, Cummings JL, Farlow MR, et al
    A Placebo-Controlled, Parallel Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191302. doi: 10.3233/JAD-191302.
    PubMed         Abstract available

  19. KIM BH, Choi YH, Yang JJ, Kim S, et al
    Identification of Novel Genes Associated with Cortical Thickness in Alzheimer's Disease: Systems Biology Approach to Neuroimaging Endophenotype.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD191175. doi: 10.3233/JAD-191175.
    PubMed         Abstract available

  20. DEVANAND DP, Liu X, Chunga RE, Cohen H, et al
    Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD200021. doi: 10.3233/JAD-200021.
    PubMed         Abstract available

  21. KAUR G, Poljak A, Braidy N, Crawford JD, et al
    Fluid Biomarkers and APOE Status of Early Onset Alzheimer's Disease Variants: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Apr 23. pii: JAD200052. doi: 10.3233/JAD-200052.
    PubMed         Abstract available


  22. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2020;74:407.
    PubMed        


    J Clin Psychiatry

  23. AVIDAN A, Burke A
    Identifying and Treating Insomnia in Patients Living With Alzheimer's Disease.
    J Clin Psychiatry. 2020;81.
    PubMed         Abstract available


    J Clin Psychopharmacol

  24. CHAN KWONG A, Casse-Perrot C, Costes-Salon MC, Jouve E, et al
    An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    J Clin Psychopharmacol. 2020;40:222-230.
    PubMed         Abstract available


    J Neurochem

  25. LI Z, Zhu H, Guo Y, Du X, et al
    Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15031.
    PubMed         Abstract available

  26. FONTANA IC, Zimmer AR, Rocha AS, Gosmann G, et al
    Amyloid-beta oligomers in cellular models of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15030.
    PubMed         Abstract available


    Lancet Neurol

  27. MD JH
    Can we trust The End of Alzheimer's?
    Lancet Neurol. 2020;19:389-390.
    PubMed        

  28. KARIKARI TK, Pascoal TA, Ashton NJ, Janelidze S, et al
    Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Lancet Neurol. 2020;19:422-433.
    PubMed         Abstract available


    Nat Rev Neurol

  29. ASHTON NJ, Hye A, Rajkumar AP, Leuzy A, et al
    An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
    Nat Rev Neurol. 2020 Apr 22. pii: 10.1038/s41582-020-0348.
    PubMed         Abstract available

  30. FYFE I
    APOE(*)epsilon4 promotes synucleinopathy.
    Nat Rev Neurol. 2020;16:185.
    PubMed        


    Neurobiol Aging

  31. REUS LM, Stringer S, Posthuma D, Teunissen CE, et al
    Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid.
    Neurobiol Aging. 2020 Mar 24. pii: S0197-4580(20)30091.
    PubMed         Abstract available

  32. HUO Z, Yu L, Yang J, Zhu Y, et al
    Corrigendum to brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis [Neurobiology of Aging Volume 86, February 2020, Pages 123-133].
    Neurobiol Aging. 2020 Apr 18. pii: S0197-4580(20)30123.
    PubMed        

  33. CERVERA-CARLES L, Dols-Icardo O, Molina-Porcel L, Alcolea D, et al
    Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration.
    Neurobiol Aging. 2020;92:7-11.
    PubMed         Abstract available


    Neurochem Res

  34. NGUYEN TT, Ta QTH, Nguyen TTD, Le TT, et al
    Role of Insulin Resistance in the Alzheimer's Disease Progression.
    Neurochem Res. 2020 Apr 20. pii: 10.1007/s11064-020-03031.
    PubMed         Abstract available


    Neurology

  35. SARYCHEVA T, Lavikainen P, Taipale H, Tiihonen J, et al
    Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009435.
    PubMed         Abstract available


    Neuroscience

  36. CHIDAMBARAM H, Chinnathambi S
    G-Protein coupled receptors and tau-different roles in alzheimer's disease.
    Neuroscience. 2020 Apr 23. pii: S0306-4522(20)30241.
    PubMed         Abstract available


    PLoS One

  37. ROMERO-ROSALES BL, Tamez-Pena JG, Nicolini H, Moreno-Trevino MG, et al
    Improving predictive models for Alzheimer's disease using GWAS data by incorporating misclassified samples modeling.
    PLoS One. 2020;15:e0232103.
    PubMed         Abstract available

  38. MUELLER KD, Norton D, Koscik RL, Morris MC, et al
    Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention.
    PLoS One. 2020;15:e0221985.
    PubMed         Abstract available

  39. BEACH TG, Adler CH, Zhang N, Serrano GE, et al
    Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
    PLoS One. 2020;15:e0231720.
    PubMed         Abstract available

  40. KIM JO, Lee SJ, Pyo JS
    Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis.
    PLoS One. 2020;15:e0227820.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: